Global Inhaled Corticosteroid Market Insights, Forecast to 2025

2019-01-10 / 3900.00 / Pharma & Healthcare / 111 Pages

Description

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
The global Inhaled Corticosteroid market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Inhaled Corticosteroid market based on company, product type, end user and key regions.

This report studies the global market size of Inhaled Corticosteroid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Inhaled Corticosteroid in these regions.
This research report categorizes the global Inhaled Corticosteroid market by top players/brands, region, type and end user. This report also studies the global Inhaled Corticosteroid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical

Market size by Product
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
Market size by End User
Hospitals
Clinics
Respiratory Care Centers
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Inhaled Corticosteroid market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Inhaled Corticosteroid market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Inhaled Corticosteroid companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Inhaled Corticosteroid submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Inhaled Corticosteroid are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Inhaled Corticosteroid market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Inhaled Corticosteroid Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Inhaled Corticosteroid Market Size Growth Rate by Product
1.4.2 Beclomethasone Dipropionate
1.4.3 Budesonide
1.4.4 Fluticasone Inhaler Powder
1.4.5 Mometasone
1.4.6 Others
1.5 Market by End User
1.5.1 Global Inhaled Corticosteroid Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Respiratory Care Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Inhaled Corticosteroid Market Size
2.1.1 Global Inhaled Corticosteroid Revenue 2014-2025
2.1.2 Global Inhaled Corticosteroid Sales 2014-2025
2.2 Inhaled Corticosteroid Growth Rate by Regions
2.2.1 Global Inhaled Corticosteroid Sales by Regions
2.2.2 Global Inhaled Corticosteroid Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Inhaled Corticosteroid Sales by Manufacturers
3.1.1 Inhaled Corticosteroid Sales by Manufacturers
3.1.2 Inhaled Corticosteroid Sales Market Share by Manufacturers
3.1.3 Global Inhaled Corticosteroid Market Concentration Ratio (CR5 and HHI)
3.2 Inhaled Corticosteroid Revenue by Manufacturers
3.2.1 Inhaled Corticosteroid Revenue by Manufacturers (2014-2019)
3.2.2 Inhaled Corticosteroid Revenue Share by Manufacturers (2014-2019)
3.3 Inhaled Corticosteroid Price by Manufacturers
3.4 Inhaled Corticosteroid Manufacturing Base Distribution, Product Types
3.4.1 Inhaled Corticosteroid Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Inhaled Corticosteroid Product Type
3.4.3 Date of International Manufacturers Enter into Inhaled Corticosteroid Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Inhaled Corticosteroid Sales by Product
4.2 Global Inhaled Corticosteroid Revenue by Product
4.3 Inhaled Corticosteroid Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Inhaled Corticosteroid Breakdown Data by End User

6 North America
6.1 North America Inhaled Corticosteroid by Countries
6.1.1 North America Inhaled Corticosteroid Sales by Countries
6.1.2 North America Inhaled Corticosteroid Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Inhaled Corticosteroid by Product
6.3 North America Inhaled Corticosteroid by End User

7 Europe
7.1 Europe Inhaled Corticosteroid by Countries
7.1.1 Europe Inhaled Corticosteroid Sales by Countries
7.1.2 Europe Inhaled Corticosteroid Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Inhaled Corticosteroid by Product
7.3 Europe Inhaled Corticosteroid by End User

8 Asia Pacific
8.1 Asia Pacific Inhaled Corticosteroid by Countries
8.1.1 Asia Pacific Inhaled Corticosteroid Sales by Countries
8.1.2 Asia Pacific Inhaled Corticosteroid Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Inhaled Corticosteroid by Product
8.3 Asia Pacific Inhaled Corticosteroid by End User

9 Central & South America
9.1 Central & South America Inhaled Corticosteroid by Countries
9.1.1 Central & South America Inhaled Corticosteroid Sales by Countries
9.1.2 Central & South America Inhaled Corticosteroid Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Inhaled Corticosteroid by Product
9.3 Central & South America Inhaled Corticosteroid by End User

10 Middle East and Africa
10.1 Middle East and Africa Inhaled Corticosteroid by Countries
10.1.1 Middle East and Africa Inhaled Corticosteroid Sales by Countries
10.1.2 Middle East and Africa Inhaled Corticosteroid Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Inhaled Corticosteroid by Product
10.3 Middle East and Africa Inhaled Corticosteroid by End User

11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Company Details
11.1.2 Company Business Overview
11.1.3 Sumitomo Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sumitomo Inhaled Corticosteroid Products Offered
11.1.5 Sumitomo Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Inhaled Corticosteroid Products Offered
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.Novartis Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Inhaled Corticosteroid Products Offered
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Inhaled Corticosteroid Products Offered
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanofi Inhaled Corticosteroid Products Offered
11.5.5 Sanofi Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Johnson and Johnson Inhaled Corticosteroid Products Offered
11.6.5 Johnson and Johnson Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 Company Business Overview
11.7.3 GSK Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GSK Inhaled Corticosteroid Products Offered
11.7.5 GSK Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 Company Business Overview
11.8.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AstraZeneca Inhaled Corticosteroid Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Teijin
11.9.1 Teijin Company Details
11.9.2 Company Business Overview
11.9.3 Teijin Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Teijin Inhaled Corticosteroid Products Offered
11.9.5 Teijin Recent Development
11.10 Glaxo's Advair
11.10.1 Glaxo's Advair Company Details
11.10.2 Company Business Overview
11.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Glaxo's Advair Inhaled Corticosteroid Products Offered
11.10.5 Glaxo's Advair Recent Development
11.11 Amgen
11.12 Kos Pharmaceutical
11.13 Teva Pharmaceutical

12 Future Forecast
12.1 Inhaled Corticosteroid Market Forecast by Regions
12.1.1 Global Inhaled Corticosteroid Sales Forecast by Regions 2019-2025
12.1.2 Global Inhaled Corticosteroid Revenue Forecast by Regions 2019-2025
12.2 Inhaled Corticosteroid Market Forecast by Product
12.2.1 Global Inhaled Corticosteroid Sales Forecast by Product 2019-2025
12.2.2 Global Inhaled Corticosteroid Revenue Forecast by Product 2019-2025
12.3 Inhaled Corticosteroid Market Forecast by End User
12.4 North America Inhaled Corticosteroid Forecast
12.5 Europe Inhaled Corticosteroid Forecast
12.6 Asia Pacific Inhaled Corticosteroid Forecast
12.7 Central & South America Inhaled Corticosteroid Forecast
12.8 Middle East and Africa Inhaled Corticosteroid Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Inhaled Corticosteroid Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Inhaled Corticosteroid Product Picture
Table Inhaled Corticosteroid Market Segments
Table Key Manufacturers Inhaled Corticosteroid Covered
Table Global Inhaled Corticosteroid Market Size Growth Rate by Product 2019-2025 (M Units) & (Million US$)
Figure Global Inhaled Corticosteroid Sales Market Share by Product 2014-2025
Figure Beclomethasone Dipropionate Product Picture
Table Major Manufacturers of Beclomethasone Dipropionate
Figure Budesonide Product Picture
Table Major Manufacturers of Budesonide
Figure Fluticasone Inhaler Powder Product Picture
Table Major Manufacturers of Fluticasone Inhaler Powder
Figure Mometasone Product Picture
Table Major Manufacturers of Mometasone
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Inhaled Corticosteroid Market Size Growth Rate by End User 2019-2025 (M Units)
Figure Hospitals
Figure Clinics
Figure Respiratory Care Centers
Figure Others
Figure Inhaled Corticosteroid Report Years Considered
Figure Global Inhaled Corticosteroid Market Size 2014-2025 (Million US$)
Figure Global Inhaled Corticosteroid Sales 2014-2025 (M Units)
Table Global Inhaled Corticosteroid Market Size by Regions 2014-2019 (M Units) & (Million US$)
Table Global Inhaled Corticosteroid Sales by Regions 2014-2019 (M Units)
Table Global Inhaled Corticosteroid Sales Market Share by Regions 2014-2019
Figure Global Inhaled Corticosteroid Sales Market Share by Regions 2014-2019
Figure 2018 Global Inhaled Corticosteroid Sales Market Share by Regions
Table Global Inhaled Corticosteroid Revenue by Regions 2014-2019 (Million US$)
Table Global Inhaled Corticosteroid Revenue Market Share by Regions 2014-2019
Figure Global Inhaled Corticosteroid Revenue Market Share by Regions 2014-2019
Figure 2018 Global Inhaled Corticosteroid Revenue Market Share by Regions
Table Global Inhaled Corticosteroid Sales by Manufacturers (2014-2019) (M Units)
Table Global Inhaled Corticosteroid Sales Share by Manufacturers (2014-2019)
Figure Global Inhaled Corticosteroid Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Inhaled Corticosteroid Revenue by Manufacturers (2014-2019) (Million USD)
Table Inhaled Corticosteroid Revenue Share by Manufacturers (2014-2019)
Figure Inhaled Corticosteroid Value Share by Manufacturers in 2018
Table Key Manufacturers Inhaled Corticosteroid Price (2014-2019) (USD/K Unit)
Table Inhaled Corticosteroid Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Inhaled Corticosteroid Product Type
Table Date of International Manufacturers Enter into Inhaled Corticosteroid Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Inhaled Corticosteroid Sales by Product (2014-2019) (M Units)
Table Global Inhaled Corticosteroid Sales Share by Product (2014-2019)
Figure Global Inhaled Corticosteroid Sales Market Share by Product (2014-2019)
Figure Global Inhaled Corticosteroid Sales Market Share by Product in 2018
Table Global Inhaled Corticosteroid Revenue by Product (2014-2019) (Million US$)
Table Global Inhaled Corticosteroid Revenue Share by Product (2014-2019)
Figure Global Inhaled Corticosteroid Revenue Market Share by Product (2014-2019)
Figure Global Inhaled Corticosteroid Revenue Market Share by Product in 2018
Table Inhaled Corticosteroid Price by Product 2014-2019 (USD/K Unit)
Table Global Inhaled Corticosteroid Sales by End User (2014-2019) (M Units)
Table Global Inhaled Corticosteroid Sales Share by End User (2014-2019)
Figure Global Sales Inhaled Corticosteroid Market Share by End User (2014-2019)
Figure Global Sales Inhaled Corticosteroid Market Share by End User in 2018
Figure North America Inhaled Corticosteroid Sales Growth Rate 2014-2019 (M Units)
Figure North America Inhaled Corticosteroid Revenue Growth Rate 2014-2019 (Million US$)
Table North America Inhaled Corticosteroid Sales by Countries (2014-2019) (M Units)
Table North America Inhaled Corticosteroid Sales Market Share by Countries (2014-2019)
Figure 2018 North America Inhaled Corticosteroid Sales Market Share by Countries
Table North America Inhaled Corticosteroid Revenue by Countries (2014-2019) (Million US$)
Table North America Inhaled Corticosteroid Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Inhaled Corticosteroid Revenue Market Share by Countries
Figure United States Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure United States Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (M Units)
Figure Canada Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Canada Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Mexico Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Table North America Inhaled Corticosteroid Sales by Product (2014-2019) (M Units)
Table North America Inhaled Corticosteroid Sales Market Share by Product (2014-2019)
Figure 2018 North America Inhaled Corticosteroid Market Share by Product
Table North America Inhaled Corticosteroid Sales by End User (2014-2019) (M Units)
Table North America Inhaled Corticosteroid Sales Market Share by End User (2014-2019)
Figure 2018 North America Inhaled Corticosteroid Market Share by End User
Figure Europe Inhaled Corticosteroid Sales Growth Rate 2014-2019 (M Units)
Figure Europe Inhaled Corticosteroid Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Inhaled Corticosteroid Sales by Countries (2014-2019) (M Units)
Table Europe Inhaled Corticosteroid Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Inhaled Corticosteroid Sales Market Share by Countries
Table Europe Inhaled Corticosteroid Revenue by Countries (2014-2019) (Million US$)
Table Europe Inhaled Corticosteroid Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Inhaled Corticosteroid Revenue Market Share by Countries
Figure Germany Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Germany Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure France Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure France Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure UK Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Italy Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Russia Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Inhaled Corticosteroid Sales by Product (2014-2019) (M Units)
Table Europe Inhaled Corticosteroid Sales Market Share by Product (2014-2019)
Figure 2018 Europe Inhaled Corticosteroid Market Share by Product
Table Europe Inhaled Corticosteroid Sales by End User (2014-2019) (M Units)
Table Europe Inhaled Corticosteroid Sales Market Share by End User (2014-2019)
Figure 2018 Europe Inhaled Corticosteroid Market Share by End User
Figure Asia Pacific Inhaled Corticosteroid Sales Growth Rate 2014-2019 (M Units)
Figure Asia Pacific Inhaled Corticosteroid Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Inhaled Corticosteroid Sales by Countries (2014-2019) (M Units)
Table Asia Pacific Inhaled Corticosteroid Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Inhaled Corticosteroid Sales Market Share by Countries
Table Asia Pacific Inhaled Corticosteroid Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Inhaled Corticosteroid Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Inhaled Corticosteroid Revenue Market Share by Countries
Figure China Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure China Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Japan Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Korea Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure India Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure India Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Australia Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Indonesia Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Malaysia Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Philippines Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Thailand Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Vietnam Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Singapore Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Inhaled Corticosteroid Sales by Product (2014-2019) (M Units)
Table Asia Pacific Inhaled Corticosteroid Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Inhaled Corticosteroid Market Share by Product
Table Asia Pacific Inhaled Corticosteroid Sales by End User (2014-2019) (M Units)
Table Asia Pacific Inhaled Corticosteroid Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Inhaled Corticosteroid Market Share by End User
Figure Central & South America Inhaled Corticosteroid Sales Growth Rate 2014-2019 (M Units)
Figure Central & South America Inhaled Corticosteroid Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Inhaled Corticosteroid Sales by Countries (2014-2019) (M Units)
Table Central & South America Inhaled Corticosteroid Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Inhaled Corticosteroid Sales Market Share by Countries
Table Central & South America Inhaled Corticosteroid Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Inhaled Corticosteroid Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Inhaled Corticosteroid Revenue Market Share by Countries
Figure Brazil Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Brazil Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Argentina Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Inhaled Corticosteroid Sales by Product (2014-2019) (M Units)
Table Central & South America Inhaled Corticosteroid Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Inhaled Corticosteroid Market Share by Product
Table Central & South America Inhaled Corticosteroid Sales by End User (2014-2019) (M Units)
Table Central & South America Inhaled Corticosteroid Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Inhaled Corticosteroid Market Share by End User
Figure Middle East and Africa Inhaled Corticosteroid Sales Growth Rate 2014-2019 (M Units)
Figure Middle East and Africa Inhaled Corticosteroid Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Inhaled Corticosteroid Sales by Countries (2014-2019) (M Units)
Table Middle East and Africa Inhaled Corticosteroid Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Inhaled Corticosteroid Sales Market Share by Countries
Table Middle East and Africa Inhaled Corticosteroid Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Countries
Figure GCC Countries Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure GCC Countries Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Turkey Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure Egypt Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Inhaled Corticosteroid Sales Growth Rate (2014-2019) (M Units)
Figure South Africa Inhaled Corticosteroid Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Inhaled Corticosteroid Sales by Product (2014-2019) (M Units)
Table Middle East and Africa Inhaled Corticosteroid Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Inhaled Corticosteroid Market Share by Product
Table Middle East and Africa Inhaled Corticosteroid Sales by End User (2014-2019) (M Units)
Table Middle East and Africa Inhaled Corticosteroid Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Inhaled Corticosteroid Market Share by End User
Table Sumitomo Company Details
Table Sumitomo Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Sumitomo Recent Development

Table Pfizer Company Details
Table Pfizer Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Novartis Company Details
Table Novartis Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Merck Company Details
Table Merck Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Sanofi Company Details
Table Sanofi Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Johnson and Johnson Company Details
Table Johnson and Johnson Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Johnson and Johnson Recent Development

Table GSK Company Details
Table GSK Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table GSK Recent Development

Table AstraZeneca Company Details
Table AstraZeneca Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development

Table Teijin Company Details
Table Teijin Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Teijin Recent Development

Table Glaxo's Advair Company Details
Table Glaxo's Advair Inhaled Corticosteroid Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
Table Glaxo's Advair Recent Development

Table Amgen Company Details
Table Kos Pharmaceutical Company Details
Table Teva Pharmaceutical Company Details
Table Global Inhaled Corticosteroid Sales Forecast by Regions 2019-2025 (M Units)
Table Global Inhaled Corticosteroid Sales Market Share Forecast by Regions 2019-2025
Table Global Inhaled Corticosteroid Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Inhaled Corticosteroid Revenue Market Share Forecast by Regions 2019-2025
Table Global Inhaled Corticosteroid Sales Forecast by Product 2019-2025 (M Units)
Table Global Inhaled Corticosteroid Sales Market Share Forecast by Product 2019-2025
Table Global Inhaled Corticosteroid Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Inhaled Corticosteroid Revenue Market Share Forecast by Product 2019-2025
Table Global Inhaled Corticosteroid Sales Forecast by End User 2019-2025 (M Units)
Table Global Inhaled Corticosteroid Sales Market Share Forecast by End User 2019-2025
Figure North America Inhaled Corticosteroid Sales Growth Rate Forecast (2019-2025) (M Units)
Figure North America Inhaled Corticosteroid Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Inhaled Corticosteroid Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Europe Inhaled Corticosteroid Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Inhaled Corticosteroid Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Asia Pacific Inhaled Corticosteroid Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Inhaled Corticosteroid Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Central & South America Inhaled Corticosteroid Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Inhaled Corticosteroid Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Middle East and Africa Inhaled Corticosteroid Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Inhaled Corticosteroid Value Chain
Table Inhaled Corticosteroid Customers List
Table Inhaled Corticosteroid Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory